Does progress in microfracture techniques necessarily translate into clinical effectiveness?

Table 2 Network meta-analysis summary and ranking of interventions based on the SUCRA scores

Follow-up	Outcome	Intervention	Coeffecient	Standard error	SUCRA ranking
1 yr	VAS	mFX-II	0.139	0.296	MFX-III > MFX-II > MFX-I1
		mFX-III	0.023	0.457
	KOOS	mFX-II	-2.296	2.835	MFX-III > MFX-II > MFX-I1
		mFX-III	-2.296	5.775
	Lysholm score	mFX-II	-17.008	11.160	MFX-I > MFX-III > MFX-II3
		mFX-III	-5.660	4.427
	IKDC score	mFX-II	2.782	1.811	MFX-III > MFX-II > MFX-I1
		mFX-III	4.339	2.228
	Cincinnati score	mFX-II	4.257	4.543	MFX-II > MFX-I1
	MRI filling	mFX-II	0.383	0.312	MFX-III > MFX-II > MFX-I1
		mFX-III	1.860	1.770
	MOCART score	mFX-II	11.950	7.419	MFX-III > MFX-II > MFX-I1
		mFX-III	30.700	14.168
	Adverse events	mFX-II	-0.529	0.373	MFX-III > MFX-II > MFX-I1
		mFX-III	-0.138	0.546
	Failure events	mFX-II	-0.520	0.777	MFX-II > MFX-I1
2 yr	VAS	mFX-II	0.377	0.452	MFX-III > MFX-II > MFX-I1
		mFX-III	0.690	0.795
	KOOS	mFX-II	1.899	2.971	MFX-II > MFX-I1
	Lysholm score	mFX-II	0.550	6.952	MFX-II > MFX-I > MFX-III3
		mFX-III	-19.560	9.814
	IKDC score	mFX-II	4.548	4.545	MFX-III > MFX-II > MFX-I1
		mFX-III	7.947	9.405
	Cincinnati score	mFX-II	-6.227	3.775	MFX-II = MFX-I2
	MRI filling	mFX-II	0.840	0.468	MFX-II > MFX-III > MFX-I3
		mFX-III	0.418	0.508
	MOCART	mFX-III	10.600	9.281	MFX-III > MFX-I1
5 yr	VAS	mFX-III	1.900	1.917	MFX-III > MFX-I1
	IKDC score	mFX-III	3.000	2.121	MFX-III > MFX-I1

¹Newer generations better than older generations.

²Newer generations equal to older generations.

³Newer generations worse than older generations.

VAS: Visual Analog Scale; mFX: Microfracture; KOOS: Knee Osteoarthritis Outcome Scale; IKDC: International Knee Documentation Committee; MRI: Magnetic resonance imaging; MOCART: Magnetic resonance observation of cartilage repair tissue.